References
- Hamblin T J, Orchard J A, Ibbotson R E, Davies Z, Thomas P W, Stevenson F K, et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002; 99: 1023–1029
- Hamblin A D, Hamblin T J. Functional and prognostic role of ZAP-70 in CLL. Expert Opin Ther Targets 2005; 9: 1165–1178
- Marti G, Orfao A, Goolsby C. ZAP-70 in CLL: Towards standardization of a biomarker for patient management. In History of Clinical Cytometry Special Issue. Cytometry B Clin Cytom 2006; 70: 197–200
- Poulain S, Benard C, Daudignon A, Le Baron F, Morel P, Duthilleul P. Is ZAP-70 expression stable over time in B chronic lymphocytic leukaemia?. Leuk Lymphoma 2007; 48: 1219–1221
- Boelens J, Philippe J, Offner F. B-CLL cells from lymph nodes express higher ZAP-70 levels than B cells from peripheral blood. Leuk Res 2007; 31: 719–720
- Cutrona G, Colombo M, Matis S, Reverberi D, Dono M, Tarantino V, et al. B lymphocytes in humans express ZAP-70 when activated in vivo. Eur J Immunol 2006; 36: 558–569